Actinium Pharmaceuticals, Inc. Liquidation Value
ATNM
Other
Cash & Equivalents
$48.00M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $48.00M
Total Obligations: -$9.66M
$38.34M
Per share: $1.23
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $48.00M
AR: $0
Total Obligations: -$9.66M
$38.34M
Per share: $1.23
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $48.00M
AR: $0
Inventory: $0
Total Obligations: -$9.66M
$38.34M
Per share: $1.23
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $38.34M | $1.23 |
| Liquid Liquidation Value | $38.34M | $1.23 |
| Operating Liquidation Value | $38.34M | $1.23 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $48.00M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $7.97M |
| Long-term Debt | N/A |
| Op. Lease Liability | $1.68M |
| Finance Lease | $11,000 |
| Shares Outstanding | 31.2M |
Explore all 119 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $48.00M | N/A | N/A | N/A | $7.97M | N/A | $1.68M | $11,000 |
| 2025-09-30 | $53.39M | N/A | N/A | N/A | $6.83M | N/A | $1.13M | $13,000 |
| 2025-06-30 | $59.93M | N/A | N/A | N/A | $8.31M | N/A | $1.27M | $16,000 |
| 2025-03-31 | $65.33M | N/A | N/A | N/A | $7.11M | N/A | $1.42M | $18,000 |
▼ Community Notes